USA Healthcare News Updates

 The global insulin pump market size is projected to reach USD 11.86 billion by 2028, exhibiting a CAGR of 16.0% during the forecast period. According to a report published by Fortune Business Insights, titled “Insulin Pump Market, 2022-2028”, the market’s value was USD 3.62 billion in 2020. Insulet Expands Availability of Omnipod DASH in Europe US-based Insulet Corporation announced the commercial availability of its much-acclaimed Omnipod DASH insulin delivery system across the Scandinavian countries Denmark, Norway, Finland, and Sweden in September 2020. Over the next few weeks, the system will be made available in Switzerland, Austria, Germany, France, and Belgium, along with Israel, according to the company’s press release. Equipped with an insulin pump, Insulet’s Omnipod is a tubeless insulin management solution that delivers medication non-stop for three days, eliminating the need for daily injections and enabling severe diabetics to independently regulate their condition.

  The global COVID-19 diagnostics market size was USD 16.05 billion in 2020. The market is projected to drop from USD 20.05 billion in 2021 to USD 9.20 billion in 2028 at a CAGR of -10.5% in the 2021-2028 period. This information is published by Fortune Business Insights™ in its report titled, “COVID-19 Diagnostics Market, 2021-2028.” According to our expert analysts, the coronavirus outbreak was stated as a public health emergency in January 2020 by the World Health Organization (WHO). Since then, the amount of COVID-19 positive cases in several nations has elevated drastically. As per statistical data presented by Worldometer, in May 2021, the U.S. registered the maximum COVID-19 cases across the globe, staying responsible for approximately 96.2% in the North American region. The abrupt advent of the crisis has noted augmented COVID-19 diagnostic happenings, treatment processes, and an upsurge in R&D events for the development of diagnostics, such as molecular assessments an

  The global bone graft substitutes market size is expected to reach USD 3.93 billion by 2027 while exhibiting a CAGR of 5.1% between 2020 and 2027. This is attributable to the increasing R&D initiatives and the growing adoption of synthetic bone graft substitutes globally. Fortune Business Insights in its latest report, titled, “Bone Graft Substitutes Market Size, Share & COVID-19 Impact Analysis, By Type (Autograft, Allograft, Demineralized Bone Matrix (DBM), Synthetic, and Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2027.”, observes that the market stood at USD 3.18 billion in 2019. Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/bone-graft-substitutes-market-103106 North America United States, Canada and Mexico Europe Germany, UK, France, Italy, Russia and Turkey etc.

  The global biopharmaceutical CMO market size reached USD 9.64 billion in 2020. The market valuation is slated to rise from USD 11.56 billion in 2021 to USD 26.49 billion in 2028 at a CAGR of 12.6% during the forecast duration. The market expansion will be influenced by the increasing number of novel drug development projects entering clinical pipelines. As per data published by Contract Pharma in 2019, overall drug development capacity is set to increase by more than 60% as more and more CMOs invest to help meet the future demand. Fortune Business Insights presents this information in its report titled “Biopharmaceutical CMO Market, 2021-2028.”     A biopharmaceutical Contract Manufacturing Organization (CMO) is a firm that serves other companies in the biopharmaceutical sector on a contract basis. CMOs offer a wide portfolio of services ranging from manufacturing to packaging. Relying on such organizations allows biopharmaceutical companies to outsource their production operation

  The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “ Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral

 The global stomach cancer treatment market size is expected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3% during the forecast period. One of the major forces behind the rise of this market is the increasing prevalence of cancer in general and stomach cancer in particular worldwide. The GLOBOCAN 2018, which is a report on the global burden of cancer produced by the International Agency for Research on Cancer (IARC), estimates that in 2018, new cancer cases will be around 18 million and cancer-related deaths will be close to 9.6 million. Further, stomach cancer will account for 8.2% of the new cancer cases. Statistics released by the World Cancer Research Fund (WCRF) substantiate the IARC’s findings. According to the WCRF, gastric cancer is the fourth mostly commonly diagnosed cancer worldwide, with 1 million new reported cases. As the incidence of stomach cancer increases across the globe, the demand for stomach cancer drugs will rise commensurately, spelling good news

  The global spinal muscular atrophy treatment market size is expected to reach USD 14.49 billion by 2026, exhibiting a CAGR of 28.9% during the forecast period. The rising prevalence of rare diseases around the world will fuel demand for SMA treatment in the forthcoming years, which in turn will aid the growth of the market. As per the National Policy for the treatment of rare diseases, globally, around 6000 to 8000 rare diseases are estimated to exist with new rare diseases reported on a regular basis. Furthermore, 80% of all the rare diseases are genetically originated and therefore impact children inexplicably. The survey also revealed that 50% of new cases are in children and are responsible for 35% of deaths before the age of 1 year, 10% between the ages of 1 and 5 years and 12% between 5 and 15 years. Nonetheless, “the growing initiatives by government authorities for pre-diagnosis will impact the spinal muscular atrophy (SMA) treatment market share positively during the foreca

  The global  plasma fractionation market  size is expected to showcase significant growth by reaching USD 51.83 billion by 2028. This information is published in a report by Fortune Business Insights, titled “Plasma Fractionation Market, 2021-2028.” The report further mentions that the market stood at USD 29.10 billion in 2020 and is likely to exhibit a CAGR of 6.9% between 2021 and 2028. This is attributable to the factors such as the increasing adoption of immunoglobulin and the growing focus on introducing advanced treatment solutions is expected to boost the demand for the product worldwide. Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/plasma-fractionation-market-101614 Takeda Acquires Shire to Strengthen its Footprint in Japan and the U.S. In January 2019, Takeda Pharmaceutical Company Limited announced the acquisition of Shire plc, a leading biopharmaceutical company having its headquarters in Japan. The acquisition has elevated Takeda’

  The global orthodontics market size was USD 4.76 billion in 2020. The market is USD 5.38 billion in 2021 and is expected to reach USD 16.36 billion in 2028 at a CAGR of 17.2% in the 2021-2028 period. This information is published by Fortune Business Insights™, in its report, titled, “Orthodontics Market, 2021-2028.” According to our research experts, owing to the several medical and visual reimbursement presented by the dental orthopedic treatment, the demand for these products is growing briskly. Furthermore, progressive move towards precautionary oral care, rising apprehension for sanitation of the equipment, and promising health benefits for treatment of dental malocclusion are projected to navigate the orthodontics market growth during the mentioned timeframe. Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/orthodontics-market-101587 3M’s Launch of 3M Filtek Universal Restorative to Incite Development A variation of errands and responsib